We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

Distribution Agreement for Oncology Assays

By Labmedica staff writers
Posted on 22 Apr 2002
A global distribution agreement for oncology-related serum assays in microtiter plate ELISA format has been announced by Dako A/S (Glostrup, Denmark) and Bayer Diagnostics (Tarrytown, NY, USA). More...
The assays are designed to aid oncologists in the confirmation, monitoring, staging, screening, and prognosis of cancer.

Under the terms of the agreement, which is for five years, Bayer Diagnostics Oncogene Science Group is responsible for the manufacture and technical support of the product line, while Dako is responsible for worldwide sales, marketing, and customer support.
The assays include proprietary serum tests for the Her-2/neu oncoprotein, epidermal growth factor receptor (EGFr), urokinase plasminogen activator (uPA), plasminogen activator inhibitor-1 (PAI-1), and an assay that detects the complexes between uPA and PAI-1. Also included are separate tests for measuring the total and complexed forms of prostate-specific antigen (PSA) to aid in the detection of prostate cancer.

"This agreement puts an entirely new set of unique and important oncology research and disease management products in the hands of Dako's sales force,” said Jes Ostergaard, CEO of Dako, "and it underscores our commitment to bridging the diagnostic testing of oncology patients with their treatments.”





Related Links:
Bayer
Dako

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Immobilization System
Cranial 4Pi Immobilization
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: 123RF

Existing Cardiovascular Risk Calculators Predict Several Common Cancers

Cardiovascular risk calculators are embedded in primary and secondary care to estimate 10‑year risk of heart attack or stroke from factors such as age, body mass index, and smoking. Many of these same... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.